Information  X 
Enter a valid email address

Medaphor Group PLC (MED)

  Print      Mail a friend       Annual reports

Monday 14 January, 2019

Medaphor Group PLC

Change of Name

RNS Number : 0258N
Medaphor Group PLC
14 January 2019
 

 

14 January 2019

 

MedaPhor Group plc

 

Change of name to Intelligent Ultrasound Group plc

 

MedaPhor Group plc announces that, pursuant to the resolution passed at the General Meeting held on 12 December 2018 (RNS ref: 2840K), it has changed its name to Intelligent Ultrasound Group plc (the "Company" or the "Group").  

 

The Board believes that the new name reflects the fact that the Group is no longer just a global leader in ultrasound training through simulation, but has expanded into the development of artificial intelligence (AI) software to guide and support doctors and sonographers in clinical ultrasound scanning.

 

Trading in the Group's shares under the new name will commence at 8.00 a.m. on 15 January 2019. The Company's ticker symbol will remain as "MED". The Group's website can now be found at www.intelligentultrasound.com.

 

Shareholdings will be unaffected by the change of name and existing share certificates should be retained as they will remain valid for all purposes. Any new share certificates issued will bear the name Intelligent Ultrasound Group plc. 

 

Enquiries:

Intelligent Ultrasound Group plc 

www. intelligentultrasound.com

Stuart Gall, CEO 
Wilson Jennings, CFO

Tel: +44 (0)29 2075 6534 



Cenkos Securities - Nominated Advisor and broker

Tel:  +44 (0)20 7397 8900 

Giles Balleny / Cameron MacRitchie (Corporate Finance)


Michael Johnson / Julian Morse (Sales) 




Walbrook PR 

Tel: +44 (0)20 7933 8780 or [email protected] 

Anna Dunphy / Paul McManus 

Mob: +44 (0)7876 741 001 / Mob: +44 (0)7980 541 893

 

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
CANCKQDNDBKDBDD

a d v e r t i s e m e n t